©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Oct 16, 2021; 9(29): 8694-8701
Published online Oct 16, 2021. doi: 10.12998/wjcc.v9.i29.8694
Published online Oct 16, 2021. doi: 10.12998/wjcc.v9.i29.8694
Cefoperazone sodium/sulbactam sodium vs piperacillin sodium/tazobactam sodium for treatment of respiratory tract infection in elderly patients
Xiao-Xia Wang, Yun-Jie Ge, Department of Cadre Health, Qingdao Municipal Hospital, Qingdao 266011, Shandong Province, China
Cheng-Tai Ma, Department of Emergency Medicine, The Affiliated Hospital of Qingdao University, Qingdao 266011, Shandong Province, China
Yan-Xia Jiang, Department of Pathology, The Affiliated Hospital of Qingdao University, Qingdao 266011, Shandong Province, China
Fa-Yun Liu, Wen-Gang Xu, Department of Pulmonary, Shandong Qingdao Hospital of Integrated Traditional Chinese and Western Medicine, Qingdao 266011, Shandong Province, China
Author contributions: Wang XX, Ma CT, and Xu WG designed the research study; Jiang YX and Ge YJ performed the research; Liu FY analyzed the data and wrote the manuscript; all authors have read and approved the final manuscript.
Institutional review board statement: The study was reviewed and approved by the Qingdao Municipal Hospital Institutional Review Board.
Informed consent statement: All study participants provided informed written consent prior to study enrollment.
Conflict-of-interest statement: The authors have nothing to disclose.
Data sharing statement: No additional data are available.
Corresponding author: Wen-Gang Xu, MD, Chief Physician, Department of Pulmonary Medicine, Shandong Qingdao Hospital of Integrated Traditional Chinese and Western Medicine, No. 5 Jiaxiang Road, Shinan District, Qingdao 266011, Shandong Province, China. jackyxu2021@126.com
Received: June 2, 2021
Peer-review started: June 2, 2021
First decision: June 24, 2021
Revised: July 5, 2021
Accepted: August 9, 2021
Article in press: August 9, 2021
Published online: October 16, 2021
Processing time: 135 Days and 1.2 Hours
Peer-review started: June 2, 2021
First decision: June 24, 2021
Revised: July 5, 2021
Accepted: August 9, 2021
Article in press: August 9, 2021
Published online: October 16, 2021
Processing time: 135 Days and 1.2 Hours
Core Tip
Core Tip: Antibiotics are the main treatment for respiratory tract infection in elderly patients. Piperacillin sodium/tazobactam sodium belongs to the β-lactam antibiotics class, with a wide antibacterial spectrum, and plays an important role in the treatment of diseases. In this study, the authors wanted to determine the therapeutic value and safety of different antibiotics.